Saudi big pharma Al-Dawaa sets IPO price range, begins book-building

  • 2/13/2022
  • 00:00
  • 3
  • 0
  • 0
news-picture

The company earlier announced it was offering 25.5 million shares in an IPO RIYADH: Al-Dawaa, which operates an extensive network of pharmaceutical retail in Saudi Arabia, has set the price range for its initial public offering at SR65 ($17.3) to SR73 per share. The company earlier announced it was offering 25.5 million shares in an IPO, or 30 percent of its capital of SR850 million through a sale by existing shareholders. Institutional subscription has also started on Sunday, where they are initially allocated 100 percent of the offering, but could go down to 90 percent, Al-Dawaa said in a statement.

مشاركة :